Tobira Therapeutics
(TBRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Operating Expenses | 7,823 | -4,133 | 3,523 | 4,967 | 15,664 |
| Operating Income | -7,823 | 4,133 | -3,523 | -4,967 | -15,664 |
| Interest Expense | 1,245 | 2,022 | 1,514 | 1,266 | 187 |
| Other Income | 2,036 | 493 | 2,097 | -1,412 | 3 |
| Pre-tax Income | -7,032 | 2,604 | -2,940 | -7,645 | -15,848 |
| Income Tax | N/A | N/A | N/A | 271 | N/A |
| Net Income Continuous | -7,032 | 2,604 | -2,940 | -7,916 | -15,848 |
| Net Income | $-7,032 | $2,604 | $-2,940 | $-7,916 | $-15,848 |
| EPS Basic Total Ops | -17.43 | -21.11 | -7.29 | -19.62 | -11.70 |
| EPS Basic Continuous Ops | -17.41 | -26.78 | -7.28 | -19.59 | -6.07 |
| EPS Diluted Total Ops | -17.43 | -21.11 | -7.29 | -19.62 | -11.70 |
| EPS Diluted Continuous Ops | -17.41 | -26.78 | -7.28 | -19.59 | -6.07 |
| EPS Diluted Before Non-Recurring Items | -156.89 | -232.31 | N/A | N/A | N/A |
| EBITDA(a) | $-7,532 | $4,444 | $-2,888 | $-3,929 | $-15,573 |